NCT07322094
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07322094
Title CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian Cancer
Acronym CATALINA-4
Recruitment Recruiting
Gender female
Phase Phase Ib/II
Variant Requirements No
Sponsors TORL Biotherapeutics, LLC
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Providence St. Jude Medical Center RECRUITING Fullerton California 92835 United States Details
City of Hope RECRUITING Irvine California 92618 United States Details
University of Southern California RECRUITING Los Angeles California 90007 United States Details
UCLA RECRUITING Los Angeles California 90095 United States Details
The Mayo Clinic RECRUITING Rochester Minnesota 55905 United States Details
Mt Sinai Hospital RECRUITING New York New York 10029 United States Details
Duke University RECRUITING Durham North Carolina 27705 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field